Business

Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection

Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection.

articleEaston Pharmaceuticals IncAugust 11, 20144/company/easton-pharmaceutica/news/easton-pharmaceuticals-announces-medical-marijuana-site-facility-visit-and-inspection
Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection

About this update from Easton Pharmaceuticals Inc

[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection\n \n \nEaston Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection\n \n TORONTO, ON--(Marketwired - Aug 11, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it was provided through a company agent / consultant, with a site visit / inspection of the medical marijuana grow-op facilities, located just outside of Toronto, Ontario, Canada pursuant to its previously announced option purchase agreement.\n The site visit and inspection of the MMJ facility was in advance of a final site inspection by Health Canada prior to receiving a medical marijuana grower's license under the new MMPR system which took effect on April 1st of this year. Easton Pharmaceuticals is pleased to report that the company and consultants were left extremely impressed with the high quality and thoroughness to detail of the current build out of the medical marijuana facility as per the Health Canada MMPR guidelines. New mandated security fencing has been installed to coincide with a high security vault, cages, large scale humidity control systems and video surveillance system that must be able to maintain surveillance recordings for at least a 2 year period. The facilities are near completion except for some additional electrical infrastructure that is to be delivered and installed prior to the scheduling of the final inspection by Health Canada. The electrical delays are mostly due to the fact the facilities are located in a rural area. The letter to build is only one of 43 that were granted to companies with 13 having thus far been issued licenses under the new MMPR system. Full names, pictures, videos and all other details will be provided once the completion of the final health Canada inspection has been completed.\n The site visit and inspection was important as full details of the facility are being confidentially provided to 2 potential investors, one of which includes a brokerage firm located in Toronto, Ontario, Canada, who have entered into negotiations with Easton for a possible financing which may involve a co-listing on the Canadian CNQ exchange. Any co-listing will not affect its current listing on the OTC Markets exchange, but will involve the filing of audited financial statements. Additional news and developments are e...

More updates from Easton Pharmaceuticals Inc